-
Apply UKMEC guidance when selecting contraceptive methods in women with multiple risk factors such as obesity, inflammatory bowel disease, smoking or age over 45
-
Evaluate the risks and benefits of depot medroxyprogesterone acetate (Depo-Provera) in women with cardiovascular or bone health risk factors and identify appropriate alternative contraceptive options.
-
Assess the role of drospirenone-only contraception (Slynd), including indications, counselling points, bleeding patterns and monitoring requirements.
-
Identify safe contraceptive options in the postpartum period, particularly in women with a history of venous thromboembolism.
-
Apply current guidance on emergency contraception and hormonal contraception in patients using GLP-1 receptor agonists such as tirzepatide.
-
Recognise and investigate irregular bleeding in women using hormonal contraception, including potential pharmacokinetic interactions and appropriate contraceptive optimisation.
-
Integrate menopause management and contraception considerations when counselling perimenopausal women experiencing vasomotor symptoms.